P
hotoreceptor degeneration occurs as a pathologic response to numerous environmental and genetic disorders, leading to progressive vision loss and blindness. The different types of blinding conditions-among which are inherited retinal degenerations such as retinitis pigmentosa (typified by loss of peripheral vision) and age-related macular degeneration (in which central vision is compromised)-result in enormous suffering for the affected persons and huge socioeconomic burdens on society. [1] [2] [3] [4] Despite tremendous progress in identifying disease mechanisms, few therapeutic approaches are available to limit cell demise. One general area that has received much attention is neuroprotection, by which the administration of a pharmacologic reagent can slow down cell loss without addressing directly the genetic cause. 5 Among the multiple potential approaches, neurotrophic factors represent an important subclass. 6 Several different neurotrophic factors have shown beneficial effects on photoreceptor loss in experimental animal models; these include ciliary neurotrophic factor (CNTF), 7, 8 glial cell line-derived neurotrophic factor (GDNF), 9, 10 and several members of the fibroblast growth factor (FGF) family. [11] [12] [13] [14] With respect to the latter, intraocular injections of either acidic or basic FGF (FGF-1 and FGF-2 using current nomenclature) reduced the rate of photoreceptor death in a rat model of inherited retinal degeneration. 11 The same laboratory and others examined the efficacy of FGF-2 in a range of genetic and induced degenerations, including light damage, mechanical damage, naturally occurring hereditary degeneration, and transgenic animals in vivo. [12] [13] [14] Our own laboratory has used in vitro retinal models to examine the role of FGF-2 in photoreceptor differentiation 15 and survival 16, 17 and to examine the intracellular signaling pathway recruited by FGF-2 treatment. 18 Although most of these studies have been performed using FGF-2, use of other family members as neuroprotectants has also been addressed. 19 We hypothesize that rational design of neurotrophic factorbased therapy should be based on receptor expression profiles. We demonstrated that high-affinity FGF receptors (FGFRs) are widespread throughout the retina but exhibit distinctly different distributions, depending on the type. 20, 21 FGFR-1 and FGFR-2 are expressed at high levels throughout the retina, FGFR-3 is concentrated within the inner retina, especially within the retinal ganglion cells (RGCs), 21 and FGFR-4 is abundantly expressed by photoreceptors and photoreceptor-derived retinoblastoma. 22, 23 These receptor profiles can be used as a guide to select candidate FGF family members. The preferred ligand for FGFR-3 is FGF-9, 24 and we showed this molecule exerts dose-dependent neurotrophic effects on RGCs in vitro. 21 FGF-19 (FGF-15 in the mouse 25 ) is a distant member of the FGF family and exhibits unique binding to FGFR-4. 26 Although FGF-19 was shown to be involved in the development of ocular tissue [27] [28] [29] and to be expressed by the embryonic retina, 26 nothing is known of its expression or biological effects in adult tissue. We show here that FGF-19 is expressed by cells adjacent to the photoreceptor layer and that in purified adult photoreceptor cultures, FGF-19 induces dose-and timedependent phosphorylation of FGFR-4, up-regulates the expression of specific transcription factors, improves survival,
Retinal Immunohistochemistry
Retinal immunohistochemistry was performed as described previously. 20 Human donor eyes were acquired from the University of Iowa Center for Macular Degeneration (generous gift of Gregory Hageman, University of Iowa, Iowa City, IA) and were processed within 12 hours of death. Institutional review board committee approval for the use of human donor tissues was obtained from the Human Subjects Committee of the University of Iowa. Retinas were dissected free from the posterior eyecup and fixed in 4% paraformaldehyde in phosphatebuffered saline (PBS) for 2 hours, cut into 1-cm 2 fragments, and passaged through PBS containing 10%, 15%, and 20% sucrose, respectively, each for 1 hour. Retinal specimens were frozen in OCT and sectioned at 10 m by cryostat. Sections were permeabilized in 0.1% Triton X-100 for 5 minutes, then preincubated in PBS containing 0.1% bovine serum albumin, 0.1% Tween 20, 5% normal goat serum, and 0.1% sodium azide (Buffer A) for 30 minutes. Sections were incubated in rabbit polyclonal anti-FGFR-4 IgG (sc-124, carboxyl terminal human FGFR-4; Santa Cruz Biotechnology) diluted 1:200 in buffer A overnight at 4°C. After extensive washing, slides were incubated in goat antirabbit IgG coupled to fluorescent dye (Alexa 488; Molecular Probes, Eugene, OR) 1 g/mL for 2 hours. The antibody solution also contained 1 g/mL 4,6-diaminodiphenyl-2-phenylindole (DAPI; Sigma-Aldrich, Poncy-Cergoise, France). Controls were performed by preincubating a fivefold excess of the immunizing peptide together with the primary antibody solution for 2 hours before addition to sections. Slides were rinsed thoroughly, coverslipped in PBS/glycerol 1:1, and examined under a fluorescence microscope (Optiphot 2; Nikon, Tokyo, Japan) equipped with the digital image analysis system (Visiolab; Biocom, Lyon, France). Images were prepared using imaging software (Photoshop CS 8.0; Adobe, Mountain View, CA).
Cell Culture and Growth Factor Treatments
Y79 retinoblastoma (initial seeding density, 10 5 cells/mL) was grown in 6 ϫ 35-mm culture well plates in RPMI 1640 medium containing 15% FCS for 3 days, and serum deprived for 24 to 72 hours. They were then treated with different FGFs for 24 hours-FGF-1 (50 ng/mL), FGF-2 (10 ng/mL), FGF-4 (10 ng/mL), and FGF-19 (5-100 ng/mL)-and analyzed.
Primary cultures of enriched adult pig photoreceptors were prepared as described previously. 17, 33 Retinas were dissected from adult pig eyes into fresh cold CO 2 -independent Dulbecco modified Eagle medium (DMEM), chopped into small fragments, washed twice in Ringer solution (Ca 2ϩ and Mg 2ϩ free), and incubated in 0.5 mL 0.2% activated papain (Worthington Biochemical Corp., Freehold, NJ) in the same buffer for 20 minutes at 37°C. The tissue was gently dissociated, and the pooled supernatants containing photoreceptors were centrifuged and resuspended in medium (Neurobasal A [Nb-A]; Invitrogen)/ 2%FCS and antibiotics (10 U/mL penicillin and 10 g/mL streptomycin). Viable cell numbers were estimated after trypan blue vital dye exclusion, and cells were seeded into 6 ϫ 35-mm tissue culture plates at an initial density of 5 ϫ 10 5 cells/cm 2 . Serum-supplemented medium was changed 48 hours after seeding with Nb-A-containing B-27 supplement. 17 Cultures were left 24 hours in chemically defined medium, then incubated with recombinant FGF-19 (0 -100 ng/mL) (R&D Systems) for 5 minutes to 24 hours, according to the particular experiment.
Primary cultures of retinal pigment epithelium (RPE) were prepared from adult pig eyes as described previously for bovine RPE. 34 Cells were maintained in RPMI/10% FCS. After they reached confluence, they were rinsed twice with serum-free medium, then incubated for 24 hours in chemically defined medium (RPMI alone). This medium was collected and concentrated 10ϫ to 20ϫ by solute filtration and stored at Ϫ20°C.
Protein Extraction and Western Blot Analysis after FGF-19 Stimulation
Analyses were performed largely according to previously published methods. 23 After the different incubations, cells were immediately frozen in liquid nitrogen, thawed on ice, and centrifuged (900g) for 5 minutes. Pellets were resuspended in cold lysis buffer (100 mM Tris [pH 7.4], 150 mM sodium fluoride, 1 mM EDTA, 1% Nonidet P40, protease inhibitor cocktail and phosphatase inhibitor, 1 mM NaVO 4 ) and stored on crushed ice. Antibody-tagged beads were prepared by incubating anti-FGFR-1 or anti-FGFR-4 20 g in 100 L lysis buffer with protein A-agarose beads for 2 hours at room temperature, prerinsed twice in PBS. Antibody-coated beads were incubated with photoreceptor extract overnight with gentle agitation at 4°C. Beads were washed in excess lysis buffer, sedimented, and resuspended in 10 L lysis buffer, to which was added an equal volume of Laemmli buffer. Protein concentration was determined using Bio-Rad (Hercules, CA) protein assay reagent. Equal amounts of protein were analyzed by SDS-PAGE, followed by immunoblotting. Solubilized proteins were separated by 7.5% SDS-PAGE and transferred to nitrocellulose membranes using a semidry transfer system (Bio-Rad). Membranes were blocked with TBS, 3% dry milk, and 0.1% Tween 20 for 1 hour at room temperature, then incubated with mouse monoclonal anti-phosphotyrosine (Upstate Biotechnology, Lake Placid, NY), rabbit polyclonal FGFR-4, or FGFR-1 (Santa Cruz Biotechnology) antibodies in TBS, 0.3% dry milk, and 0.1% Tween 20 overnight at 4°C. Bound primary antibody was detected by means of horseradish peroxidase-conjugated goat anti-mouse or goat anti-rabbit secondary antibodies diluted 1:10,000 in TBS, 0.3% dry milk, and 0.1% Tween 20 for 2 hours at room temperature. Immunoreactive bands were visualized using an enhanced chemiluminescence kit according to the manufacturer's instructions (SuperSignal ECLϩ; Pierce Biotechnology, Brebières, France).
Messenger RNA Extraction from Retina and RPE
Total RNA was extracted from freshly isolated adult pig RPE and retina using the (RNAble; Eurobio Laboratoires, Courtaboeuf, France) kit according to the manufacturer's instructions. Neural retinas were removed from posterior eyecups, and RPE was harvested by trypsin digestion followed by gentle aspiration. 34 Fragments of DNA of FGF-19, ␤-actin, and RPE65 were amplified from total RNA by reverse transcriptase-polymerase chain reaction (RT-PCR) with the use of specific primers chosen from a BLAST search of highly conserved sequences within the databank or from published sequence data 35 : FGF-19 forward, 5Ј CTCTMCAGCTGCTTYCTGCGCATC; FGF-19 reverse, 5Ј TTG-TAGCCRTCDGGRCGGATCTCC (expected product size, 232 bp); RPE-65, forward, 5Ј AATGGATTTCTGATTGTGGA; RPE-65 reverse, 5Ј TCAGGATCTTTTGAACAGTC (expected product size, 642 bp); ␤-actin forward, 5Ј ATCCACGAAACTACCTTCAACTC; ␤-actin reverse, 5Ј GAG-GAGCAATGATCTTGATCTTC (expected product size, 177 bp).
After 30 cycles of amplification, PCR products were separated by electrophoresis in 2% agarose gels and visualized by ethidium bromide staining.
NRL Immunochemistry
For immunocytochemical studies, medium was removed 24 hours after FGF-19 treatment, and cells were fixed in 4% paraformaldehyde in PBS for 15 minutes. Cells were permeabilized for 5 minutes using 0.1% Triton X-100, then preincubated in blocking buffer (PBS containing 0.1% bovine serum albumin, 0.1% Tween 20, and 0.1% sodium azide) for 30 minutes. Cells were incubated overnight in affinity-purified anti-NRL antiserum (1:1000 dilution) and monoclonal anti-rhodopsin antibody rho-4D2, rinsed thoroughly, and incubated with secondary antibodies (anti-rabbit IgG-Alexa 594 and anti-mouse IgG-Alexa 488) combined with 4,6-di-amino-phenyl-indolamine (DAPI) (all from Molecular Probes) for 2 hours. Cells were washed, mounted in PBS/ glycerol, and examined under a fluorescence microscope (Optiphot 2; Nikon). All images were captured using a charge-coupled device camera and transferred to a dedicated personal computer. The same capture parameters were used for each stain, and final panels were made using untreated images for direct comparison of staining intensities. 36 For immunoblotting studies, cells were sonicated in PBS, and clarified supernatant was used for further analysis. Protein concentration was determined using Bio-Rad protein assay reagent. Equal amounts of proteins were analyzed by SDS-PAGE, followed by immunoblotting. Proteins were detected using anti-NRL polyclonal antibody as described. 31, 36 Immunoblots from three independent experiments were analyzed.
Cell Proliferation and Survival Assays
Y-79 cells were grown in 6 ϫ 35-mm tissue culture plates as described, then serum-deprived by maintenance in RPMI medium alone for 72 hours. Recombinant human FGF-19 (10 -100 ng/mL) was then added to each well, with negative controls receiving the same volume of medium alone and positive controls receiving RPMI/15% FCS. Cultures were left for 24 hours, and the cells were collected and sedimented at 1000g for 10 minutes. Viable cell numbers were determined by counting on a hemocytometer (under conditions of trypan blue exclusion to exclude dead cells), with triplicate wells for each concentration.
Adult pig photoreceptor cultures were prepared as described and transferred to Nb-A alone for 24 hours, and test wells were supplemented with increasing concentrations of FGF-19 (10 -100 ng/mL) for 24 hours at 37°C. Cell viability was assayed using the validated neutral red vital dye uptake assay 37 (Sigma-Aldrich Sarl, Saint Quentin Fallavier, France). The medium was discarded, and the cultures were washed with PBS. Cells were incubated in assay solution (0.033% neutral red in HEPES buffer, pH 7.4) and incubated for 2 hours at 37°C. Thereafter, cells were washed twice with the same buffer and dried at room temperature, and the neutral red dye was extracted in solubilization buffer (1% acetic acid, 50% ethyl alcohol). Optical density was measured at 570 nm, and data were expressed as arbitrary units.
RESULTS
We examined the presence of FGFR-4-like immunoreactivity within the adult postmortem human retina; although antibody binding was visible throughout the retina, especially heavy immunolabel was present at the surfaces of the photoreceptor inner segments (Fig. 1) . This location suggested that such receptors might be activated by ligands within the subretinal space, and we then searched for the presence of FGF-19 within one of the principal cell types-the RPE-bordering this space. FGF-19 mRNA was clearly detected in extracts prepared from adult pig RPE primary cultures and in extracts of neural retina ( Fig. 2A) . When amplified PCR products were normalized to ␤-actin obtained from the same samples (Fig. 2B) , FGF-19 expression was higher in RPE than in retina. Coamplification of mRNA of the RPE-specific marker RPE65 showed strong label in the RPE, as expected, and the presence of a faint band in neural retina preparations (Fig. 2C) .
Immunoblotting for the presence of FGF-19 protein was performed on a number of cell preparations. SUM and Y-79 retinoblastoma exhibited a major immunoreactive band of approximately 34 kDa, within both cellular and extracellular (conditioned medium) compartments (Fig. 3) . Retina, on the other hand, showed relatively low levels of this immunoreactive band, particularly in the conditioned medium fraction; RPE had intermediate levels, both in cell cytoplasm and medium fractions (Fig. 3) . Y-79, retina, and RPE cellular fractions also displayed a weaker band at approximately 37 kDa.
Addition of recombinant human FGF-19 to serum-deprived Y-79 cells led to dose-dependent increases in proliferation (Fig.  4A) . Importantly, the addition of recombinant human FGF-19 to purified adult porcine photoreceptors maintained in chemically defined medium led to a dose-dependent increase in cell survival. The addition of 10 ng/mL increased survival by 48%, to the same extent as the readdition of 2% FCS. The addition of 20 and 40 ng/mL increased survival by approximately 100% in both cases (Fig. 4B) .
Analysis of FGF-19 phosphorylation of FGFR-4 was performed using Y-79 cells and cultured photoreceptors. Both cell types gave similar profiles by antiphosphotyrosine immunoblotting of protein immunoprecipitated using anti-FGFR-4 antibody. A single band of approximately 80 kDa was detectable, showing faint labeling in unstimulated, and after 5 and 10 minutes of FGF-19 treatment, then becoming progressively stronger by 20 and 30 minutes. The 80 kDa band was still activated after 45 minutes (Fig. 5) . In parallel experiments, we immunoprecipitated FGF-19 -treated cultures with anti-FGFR-4 antibody and then immunoblotted the membranes with anti-FGFR-1. FGFR-1 immunoblotting of proteins pulled down by anti-FGFR-4 showed a single band of approximately 110 kDa, present at all time points examined, but with increasing intensity after FGF-19 addition at 5 minutes and maximal at 15 minutes; thereafter, the intensity of the band decreased but was still not at baseline levels by 45 minutes (Fig. 5C) .
We also examined the effects of the addition of FGF-19 on steady state expression levels of Nrl, a key rod-specific transcription factor involved in photoreceptor differentiation and survival. In Y-79 retinoblastoma, serum starvation led to almost complete disappearance of Nrl expression; the addition of FGF-19 led to a dose-dependent reappearance of this factor, with increased expression at 10 ng/mL and strong reexpression with 100 ng/mL (Fig. 6A ). Other FGFs with published affinity for FGFR-4 were also tested for their capacity to stimulate Nrl levels. FGF-1, FGF-2, and FGF-4 were all tested in this assay and found to enhance Nrl expression (Fig. 6B ). Immunocytochemical staining of purified adult photoreceptor cultures for rod opsin and Nrl supported these data. Depletion of serum led to weak staining of Nrl within rod nuclei, whereas supplementation with FGF-19 led to increased nuclear levels (Fig. 6C) .
Finally, because we detected FGF-19 in conditioned medium prepared from RPE monolayers, we also examined the effects of this conditioned medium on some of the parameters investigated for FGF-19. Notably, the incubation of adult photoreceptor cells with RPE medium led to weak tyrosine phosphorylation of a band of approximately 80 kDa (Fig.   7A ). Such treatment also led to increased levels of at least one Nrl isoform (approximately 35 kDa), as seen in Western blots (Fig. 7B) . 
DISCUSSION
These data suggest strongly that FGF-19, acting through FGFR-4 localized within photoreceptors, exerts beneficial effects on photoreceptor survival and phenotypic expression. Furthermore, the detection of endogenous FGF-19 within and secreted by the adjacent RPE suggests that FGF-19 may play a role in mature photoreceptor physiology in vivo. We detected FGF-19 mRNA and protein within the different cell types tested, with some variation, depending on the cell type and compartment. By our immunoblotting experiments, native FGF-19 had an apparent molecular mass (approximately 34 kDa) superior to the calculated weight (21 kDa) and hence did not migrate as expected. We were unable to find other published data on native FGF-19, but such behavior may be related to the unusual protein structure. 38 In addition, a second, fainter, immunoreactive band was seen at approximately 37 kDa, present in all the cellular fractions but absent from media (except for Y-79 cells; Fig. 3 ). FGF-19 is unusual for an FGF family member in that it has a 22-amino acid signal sequence. 39 Hence, the longer immunoreactive form present in cell extracts may represent this precursor. Possibly the Y-79 medium preparation was contaminated with lysed cellular material; indeed, this preparation also contained an approximately 32-kDa immunoreactive band, which may represent a partially proteolyzed form. Among the different tissue samples, retina contained the least FGF-19. This is consistent with published reports showing that it is strongly expressed in developing retina but that it downregulates shortly after birth to become restricted to some inner retinal cells. 28 Of the five known high-affinity FGFRs, FGFR-4 is relatively little studied, especially within the central nervous system. In the mature brain, it is reported to be expressed principally within the median habenular nucleus, 40 whereas we have shown previously that it is expressed by adult retina, 20, 22 predominantly within photoreceptors. It is more widely expressed during the development of the central nervous system 39 and has been reported to be a precocious marker of human macula, where it may play a role in cone differentiation. 41, 42 Transgenic Xenopus, carrying a dominant-negative FGFR-4 construct targeted to the retina, displays profound defects in retinal formation, 43 underscoring the importance of this receptor in retinal development. Although the activation and intracellular signaling of FGFR-4 are only poorly known, data indicate several notable differences with respect to the other FGFRs. When transfected into COS cells, FGFR-4 is the only FGFR that induces membrane ruffling, indicative of cytoskeletal reorganization. 44 Originally reported to constitute a specific high-affinity receptor for FGF-1, 45 FGFR-4 activation is prolonged compared with FGFR-1, and there is only weak tyrosine phosphorylation of intracellular proteins, including mitogen-activated protein kinase. 46, 47 Ligand binding has been reported to activate a unique 85-kDa protein with serine/ threonine phosphorylation activity. 48 Some of these characteristics were also seen in the studies performed here. FGF-19 binding led to delayed but prolonged receptor activation, with tyrosine phosphorylation still observed after 45 minutes. By comparison, FGFR-1, present in photoreceptors, is rapidly (within 30 seconds) activated by FGF-2 and deactivates within 5 to 10 minutes. 16, 18 In the studies performed here, immunoprecipitation of FGF-19 -stimulated cells and immunoblotting with phosphotyrosine antibody revealed a band of approximately 80 kDa, which may represent the associated intracellular signaling protein or an isoform of FGFR-4 itself. Interestingly, we observed coimmunoprecipitation of FGFR-1 and FGFR-4 after FGF-19 stimulation of cultured cells. Immunoblotting for FGFR-1 in FGFR-4 -immunoprecipitated material detected a single band at approximately 110 kDa, in accordance with one of the FGFR-1 isoforms observed in previous studies of the retina. 18 The intensity of this band varied, depending on the duration of FGF-19 stimulation; it was maximal after 15 minutes, indicating that the formation of FGFR-1/FGFR-4 heterodimers increased after receptor activation. To the best of our knowledge, this is the first time dimerization between these two receptors has been identified. Our previous studies indicate that photoreceptors contain mainly FGFR-1 and FGFR-4 in approximately equal concentrations. 19, 20, 22 It is, hence, plausible that the two forms interact physically on ligand binding. However, we have no formal proof that FGF-19 uniquely activates FGFR-4, as has been reported under cell-free conditions. 26 Cellular context is very important in determining receptor-binding interactions, and these parameters have not been examined in detail within the retina. Finally, very recent studies demonstrate the existence of coreceptors that interact with FGFR-4, termed ␣Klotho and ␤Klotho. 49, 50 Highly abundant in liver and fat cells, these single-span transmembrane proteins increase FGF-19/FGFR-4 interactions in a heparin-dependent manner, suggesting a complex receptor organization for this factor. It will be of great interest to see whether ␣Klotho and ␤Klotho are expressed in retina.
Data have accumulated to indicate a primary role of FGF-19/FGFR-4 in lipid metabolism and energy storage. Transgenic mice that overexpress FGF-19 exhibit an accelerated metabolism, with decreased adipose tissue. 51 FGFR-4 knockout mice show defects in the bile acid synthetic pathway. 52 No observations were reported on any retinal changes, but it would obviously be of interest to see whether any of these lines have ocular modifications. FGFR-1 Ϫ/Ϫ /FGFR-4 Ϫ/Ϫ hybrids would be an interesting model to examine, but FGFR-1 Ϫ/Ϫ mice die during gestation from failure of the embryo to implant in the uterus. 53 One potential approach would be through the use of D-F) . Addition of FGF-19 (50 ng/mL) for 24 hours restored Nrl expression levels (G-I). All images were exposed using the same conditions. Scale bar, (I) 12 m. In all cases, the readdition of FCS served as positive control. specific siRNA to inhibit FGFR transcription. In the studies presented here, FGF-19 and several other tested FGFs showed positive effects on expression levels of Nrl. This rod-specific transcription factor is vital for normal rod differentiation, 54 and mutations in the phosphorylation site serine 50 lead to retinitis pigmentosa. 55 We chose FGFs known to exhibit elevated binding affinity for FGFR-4 56 and all (FGF-1, FGF-2, FGF-4, FGF-19) stimulated Nrl levels in retinoblastoma and primary photoreceptors. We also observed an inductive effect by RPE-conditioned medium, which contains at least FGF-2 57 and FGF-19 (data presented here). Endogenous expression profiles of Nrl differ, depending on the tissue (retinoblastoma, purified photoreceptors, whole retina 31, 36 ) , and the stimulatory effects also differed between the different models (i.e., a 30-kDa isoform was up-regulated in Y-79 cells, whereas an approximately 34-kDa protein was up-regulated in photoreceptors). Nevertheless, this resembles the stimulatory effect recently seen for retinoic acid 36 and might indicate a general role for soluble signaling factors and posttranslational control of transcription within rod photoreceptors. These in vitro data indicate that FGF-19 should be added to the list of other growth factors exhibiting beneficial effects on photoreceptor survival. Within the FGF family itself, these include FGF-1, 11,12 FGF-2, 11-14 FGF-5, and FGF-18. 19 Advocacy of the FGFs as potential therapeutic approaches to retinal degeneration has declined over recent years because of the potential for such agents to induce neovascularization. 58 However, several lines of research have indicated that ocular FGF treatment does not necessarily translate into increased blood vessel growth. 59 The capacity of FGF-19 to stimulate blood vessel development has not been reported. FGFR-4 is expressed by some vascular endothelial cells, and its overexpression is associated with different neoplastic tissues. 60 Overall, its activation induces only a weak mitogenic response in various lines, 45, 46 and experimental evidence suggests this difference comes from the structure of the cytoplasmic domain because chimeric receptors with amino terminal FGFR-4 and cytoplasmic terminal FGFR-1 display mitogenic characteristics. 46 However, in the present study, FGF-19 was clearly strongly mitogenic for Y-79 retinoblastoma, raising potential concerns over any potential clinical application. 
